BAMM — Body and Mind Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual cashflow statement for Body and Mind, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2019 July 31st | 2020 July 31st | 2021 July 31st | R2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.75 | -4.6 | -1.98 | -29.2 | -20.3 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.35 | 0.895 | 1.76 | 24 | 11.4 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.446 | 2.24 | -1.17 | -0.398 | 3.93 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.56 | -2.31 | 0.295 | -3.56 | -3.66 |
Capital Expenditures | -0.368 | -0.872 | -0.402 | -0.265 | -0.993 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -8.81 | -4.47 | -0.43 | -1.88 | 0.918 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -9.18 | -5.34 | -0.832 | -2.15 | -0.074 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 20.1 | 0.091 | 6.17 | -0.027 | 3.52 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.68 | -7.65 | 6.02 | -5.63 | 0.042 |